Ronald W. Watson

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer.

Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer.

Journal: BJUI compass

Published: October 21, 2024

A novel family of beta mixture models for the differential analysis of DNA methylation data: An application to prostate cancer.

A novel family of beta mixture models for the differential analysis of DNA methylation data: An application to prostate cancer.

Journal: PloS one

Published: March 19, 2024

Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer.

Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer.

Journal: European urology focus

Published: February 01, 2023

Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor.

Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor.

Journal: Cancers

Published: December 16, 2021

Integrating Serum Biomarkers into Prediction Models for Biochemical Recurrence Following Radical Prostatectomy.

Integrating Serum Biomarkers into Prediction Models for Biochemical Recurrence Following Radical Prostatectomy.

Journal: Cancers

Published: July 15, 2021

Correlation of integrated ERG/PTEN assessment with biochemical recurrence in prostate cancer.

Correlation of integrated ERG/PTEN assessment with biochemical recurrence in prostate cancer.

Journal: Cancer treatment and research communications

Published: June 21, 2021

Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer.

Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer.

Journal: Cancers

Published: October 25, 2020

Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling.

Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling.

Journal: International journal of molecular sciences

Published: October 22, 2020

Integrating inflammatory serum biomarkers into a risk calculator for prostate cancer detection.

Integrating inflammatory serum biomarkers into a risk calculator for prostate cancer detection.

Journal: Scientific reports

Published: September 02, 2020

A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort.

A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort.

Journal: BMC medical informatics and decision making

Published: March 02, 2020

The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer.

The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer.

Journal: Oncotarget

Published: August 06, 2019

Transcriptomic signatures for tertiary pattern 5 in prostate cancer.

Transcriptomic signatures for tertiary pattern 5 in prostate cancer.

Journal: BJU international

Published: June 18, 2019

Showing 1-12 of 37

Last Updated: 09/26/2026